Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2026-01-01 @ 10:46 PM
Study NCT ID:
NCT06698003
Status:
RECRUITING
Last Update Posted:
2025-03-04
First Post:
2024-11-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-15
Start Date Type:
ACTUAL
Primary Completion Date:
2029-11-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-11-15
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-18
First Submit QC Date:
None
Study First Post Date:
2024-11-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-03
Last Update Post Date:
2025-03-04
Last Update Post Date Type:
ACTUAL